跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 44,169 条关于
“Theralase Technologies Inc.”
全部
44,169
临床试验
11,748
药物
1,752
机构
6,306
资讯
24,363
去年
Theralase Technologies Reports Promising Phase 2 Bladder Cancer Data and Outlines Funding Strategy
去年
Theralase Closes Private Placement to Advance Bladder Cancer Clinical Study
去年
Theralase Technologies Advances Bladder Cancer Treatment with Promising Phase II Trial Results
去年
Theralase's Ruvidar Shows Promise as DUB Inhibitor in Cancer Treatment Breakthrough
去年
Theralase Expands Bladder Cancer Clinical Trial with New Sites and Promising Phase II Data
去年
Theralase's Rutherrin Shows Promise in Non-Hodgkin's Lymphoma Treatment When Combined with Metformin and Radiation
9个月前
Theralase Completes Enrollment of 90 Patients in Phase II Bladder Cancer Study for Light-Activated Ruvidar
18天前
Theralase Reports 65.2% Complete Response Rate in Phase II Bladder Cancer Study, Plans NDA Filing in 3Q2026
10个月前
Theralase's Rutherrin Shows 100-Fold Cancer Cell Kill Enhancement in Preclinical Studies
去年
Theralase's Light-Activated Bladder Cancer Therapy Shows Promising Results in Phase II Trial
第 1 页，共 2437 页
上一页
下一页
